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Edited by Hans EklundAbstract The recently described pneumococcal histidine triad
protein family has been shown to be highly conserved within
the pneumococcus. As part of our structural genomics eﬀort on
proteins from Streptococcus pneumoniae, we have expressed,
crystallised and solved the structure of PhtA-166–220 at 1.2 A˚
using remote SAD with zinc. The structure of PhtA-166–220
shows no similarity to any protein structure. The overall fold
contains 3b-strands and a single short a-helix. The structure ap-
pears to contain a novel zinc binding motif. The remaining 4 his-
tidine triad repeats from PhtA have been modelled based on the
crystal structure of the PhtA histidine triad repeat 2. From this
modelling work, we speculate that only three of the ﬁve histidine
triad repeats contain the residues in the correct geometry to al-
low the binding of a zinc ion.
 2005 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Structural genomics is ﬂourishing owing to tremendous pro-
gress in genome sequencing as well as recent advances in com-
puter and software technology and third generation
synchrotron beam-lines for macromolecular crystallography.
One of the goals of structural genomics is to map the entire
folding space. This can be accomplished by solving the struc-
tures of a large number of carefully selected proteins (15–
20000) that show no signiﬁcant sequence homology to each
other, and are therefore likely to include the majority of pro-
tein folds [1]. It is anticipated that this eﬀort will expand
knowledge of protein structure and will facilitate solving the
structures of other proteins. For many proteins, function has
not yet been established. It is expected that structural genomics
will be able to assign functions to proteins when assignment is
not possible from sequence alignment alone [2–8]. This is espe-
cially important as thousands of newly identiﬁed open reading
frames representing putative protein genes became available
from genome-sequencing programs. Structural information
may provide important functional clues. The selection of pro-*Corresponding author. Fax: +44 141 330 4888.
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genomics approach [9]. In this work, we applied the following
three criteria: (i) uniqueness of amino acid sequence, to in-
crease chances of ﬁnding a new protein fold (ii) unknown func-
tion, to aid in assignment of function, (iii) origin from a
pathogenic bacterium to provide a basis for future investiga-
tion of the protein as a potential drug target.
As part of a pilot structural genomics exercise, we have cho-
sen a subset of proteins of bacterial origin which have an un-
known function and/or structure, the initial subset were all
proteins from the human pathogen Streptococcus pneumoniae
as two complete genomes are available in the public domain
for this organism. We have chosen to work with the Tigr4
strain (http://www.tigr.org).
The ﬁrst proteins screened for crystallisation, are those that
are speciﬁc to the pneumococcus. PhtA is part of a family of
uncharacterised proteins that are unique to the pneumococcus
and would represent a speciﬁc drug target for this organism
[10,11]. The proteins in this family are approximately 800 ami-
no acids in length and show very strong sequence conservation
within the pneumococcus. PhtA (SP1175) is a member of a no-
vel family of cell surface exposed pneumococcal proteins (Pht
family, consisting of PhtA, PhtB, PhtD and PhtE) [10]. This
family includes members that can induce antibodies capable
of protecting mice against pneumococcal sepsis and death.
These proteins were identiﬁed from the S. pneumoniae genome
database and were selected based on their putative hydropho-
bic leader sequence, which are characteristic of proteins ex-
ported across the cytoplasmic membrane [12]. These novel
pneumococcal antigens, either alone or in combination with
capsular polysaccharides, could serve as eﬀective vaccines
against the most prevalent pneumococcal serotypes.
PhtA (SP1175) is a protein of 816 amino acids, and contains
ﬁve histidine triad repeats which contain the HxxHxH motif.
These proteins were therefore termed Pht (pneumococcal histi-
dine triad) due to the characteristic repeats [10]. Experiments
using surface exposed proteins in immunisation trials in mice
[12], revealed that the N-terminus residues of PhtA (18–230)
caused the production of antibodies which protected mice
against death following intraperitoneal challenge with two
strains of S. pneumoniae 6B and 6A. Immunization with PhtA
resulted in antibodies that were cross reactive to proteins from
several strains of S. pneumoniae [13] and further work by Ha-
mel et al. [14] has shown protective antibodies are produced by
PhtB (BHV3) in immunized mice.
The protein studied here, PhtA (SP1175) from S. pneumo-
niae belongs to a family/class of proteins that are unique toation of European Biochemical Societies.
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bacterial species. Neither its biological function or catalytic
properties (if any) have been characterised. We have deter-
mined the high-resolution structure of a single histidine triad
repeat domain of PhtA residues (166–220) by SAD analysis
of the native protein (shown to contain zinc ions). The protein
fragment adopts a simple motif consisting of 3 beta strands
and a single alpha helix (linked by short loops).Table 1
Data collection and reﬁnement statistics
Data collection
Resolution (A˚) 72.548–1.2 (1.26–1.2)
Number of frames (rotation per frame ) 360 (1)
Total observations 593315
Unique reﬂections 49793
Completeness (%) overall/highest shell 93.9 (93.9)
Mean I/overall/highest shell 8.1/2.6
Rsym (%) overall/highest shell 4.7/17.5
Multiplicity overall/highest shell 7.6/7.22. Materials and methods
2.1. Expression and puriﬁcation
A PCR product containing the coding region for part of the N-ter-
minal domain (residues 18–230) of the PhtA protein was cloned be-
tween the BamHI and HindIII sites of the pQE-10 vector (Qiagen) in
frame with an N-terminal His6 tag. The recombinant protein was puri-
ﬁed by nickel aﬃnity chromatography, the protein concentrated using
an Amicon pressure cell followed by gel ﬁltration. The protein was
concentrated for use in crystal trials to 7 mg/ml1 in 200 mM NaCl,
25 mM Tris and 4 mM imidazole (pH 7.5). S. pneumoniae PhtA-166–
220 domain crystallised using a mother liquor of 1.6 M ammonium sul-
fate and 0.1 M HEPES at pH 7.0 at 20 C using hanging drop vapour
diﬀusion. A single crystal was obtained from 4 ll drops containing
equal volumes of protein and reservoir solution, over a period of 18
months [15]. The crystal belongs to the space group C2 with unit cell
parameters a = 62.18 A˚, b = 35.89 A˚, c = 72.54 A˚, b = 90.01 with
three molecules per asymmetric unit.
2.2. Data collection and processing
The crystal was ﬂash cooled at 100 K using dried paraﬃn oil as the
cryoprotectant [16]. Data were collected to 1.2 A˚ at the XRD-1 Beam-
line at Elettra using a MarCCD detector. A total of 372 images were
collected using a 1 oscillation range per image at a wavelength of
1.0 A˚. The data were processed and merged using MOSFLM [17]
and SCALA [18] keeping the Bijvoet pairs separate during scaling.
Intensities were converted to structure factor amplitudes using the
CCP4 suit [19] program TRUNCATE [20].
2.3. Structure solution
The positions of three zinc ions were located using autoSHARP [21].
Position reﬁnement and phase calculation were performed using
SHARP [21]. This was followed by a further round to include density
modiﬁcation (solvent ﬂipping) using SOLOMON [22] as implemented
in SHARP. This provided a solution that gave excellent phases for
model building using Arp/Warp [23]. The remainder of the model
was built by hand using Quanta (Accelerys, San Diego, CA, USA) with
reﬁnement carried out using REFMAC5 [24]. The model was validated
using PROCHECK [25] and WHATCHECK [26].Phasing
Wavelength (A˚) 1.0
Number of zinc sites 3
FOM (centric/acentric) 0.21743/0.55428
Anomalous phasing power (Acentric) 3.15
Reﬁnement
Space group C2
Unit cell parameters a = 62.18 A˚, b = 35.89 A˚,
c = 72.54 A˚, b = 90.01
Resolution limits 72.5–1.2 A˚
R/Rfree 11.2/13.5
No. atoms 1410
No. water molecules 195
No. zinc ions 3
Mean B value overall (A˚2) 8.828
R.m.s. deviations
Bond length (A˚) 0.16
Bond angle () 1.93
Values in parentheses are for the outer shell.3. Results and discussion
3.1. Structure solution and zinc sites
Residues 18–220 of S. pneumoniae PhtA were expressed with
a 6-his tag in Escherichia coli. Following aﬃnity puriﬁcation to
immobilised metal ions, the pure protein samples were concen-
trated to 3 ml and the PhtA domain puriﬁed to homogeneity
by size-exclusion chromatography. Fractions containing pure
PhtA were pooled, concentrated and used in crystal trials. A
diﬀraction quality crystal grew after 18 months. Initial phases
were calculated based on the zinc ion sites, located by use of
anomalous diﬀerence Patterson, to verify the presence of
anomalous scatterers [19]. The positions of the Zn ions were
determined using autoSHARP with data in the resolution
range from 76.0 to 1.2 A˚ [21], three sites were found. Positional
reﬁnement and phase calculations were performed usingSHARP [21]. Phases were further improved by solvent ﬂipping
using SOLOMON [22] as implemented in SHARP [21]. A free-
atom model was built into the electron density calculated from
the solvent ﬂipped phases using ARP/wARP [23]. The resulting
electron density maps were high quality and allowed auto-trac-
ing of the amino-acid chain using ARP/wARP warpNtrace [23]
version 6.0 integrated into CCP4i, which allowed the auto-
matic building of 129 residues in 7 chains. Initial reﬁnement
was performed using REFMAC5 [24] from the CCP4 program
suite [19]. Rounds of model building using (Quanta) (Accele-
rys, San Diego, CA, USA) and REFMAC5 [24] allowed all
residues to be built into the electron density maps. Application
of anisotropic reﬁnement of B factors as implemented in REF-
MAC5 [24] followed by rounds of reﬁnement using TLS [27]
improved both the R factor and the Rfree. Solvent molecules
were then added manually in density peaks greater than 4.0
sigma. Data collection/reﬁnement, phasing and ﬁnal model
statistics are shown in Table 1. Figures were produced with
Molscript [28], Bobscript [29] and Raster3D [30]. The ﬁnal
structure contains three independent copies of the histidine
triad motif, chains A and B contain 54 residues whilst chain
C contains only 53 residues, there are also 3 zinc ions (one
associated with each histidine triad motif) and a total of 195
water molecules.
As the PhtA protein shares no sequence homology to any
protein of known structure, it was not expected to be possible
to solve the structure by molecular replacement and as the
crystal took a long time to grow (over 18 months) it made
the growth of new crystals for heavy atom trials unlikely. As
the protein was thought to contain several histidine triad re-
peats we expected that metal ions would have bound to the
protein during the expression and subsequent puriﬁcation, as
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zinc. It is speculated that the binding of zinc ions by the histi-
dine triad motifs would confer the functional conformation on
the proteins [10,31]. We decided to try a remote SAD (single
wavelength anomalous diﬀraction) approach and collected
the data at a wavelength of 1.0 A˚, where a zinc atom would
provide three anomalous electrons. We therefore scaled the
data keeping the Bijvoet pairs separate. The resulting anoma-
lous Patterson revealed the presence of three peaks which were
subsequently reﬁned as Zn ions.
The protein that was used in the crystallisation trials was
the full-length construct (residues 18–230), as characterised
by Gel Filtration chromatography, SDS–PAGE Gel electro-
phoresis and dynamic light scattering (data not shown). Cal-
culation of the Matthews coeﬃcient and solvent content [32]
suggested that the asymmetric unit would contain a single
molecule of approximately 200 amino-acid residues (Mat-
thews coeﬃcient 1.80 solvent content 31.11%). However, on
elucidation of the structure it became clear that the asymmet-
ric unit did not contain a single molecule but instead was
formed from three repeating units, each of which had a single
zinc ion bound. The protein had been degraded over the 18
months it took for the crystal to grow. The protein contained
within the crystal consisted of residues 166–220 only (this in-
cludes only one of the histidine triad repeats). It is thought
that a contaminant protein containing proteolytic activity
(either in the puriﬁed protein or as a contaminant on the
plastic-ware used to setup the screens) had caused the break-
down of the protein over time, however, we cannot rule out
the possibility that the protein itself (PhtA-18–220) has some
proteolytic activity. Proteolytic activity has been observed for
the homologous protein PhtB [14]. Trials of the potential
proteolytic activity of this protein have been undertaken
and subsequent batches of puriﬁed protein have been stored
at 4 C for a period of 2–3 months (crystals were grown at
20 C). The initial puriﬁed protein ran on an SDS–PAGE
gel as a single band (with no contaminating bands by Com-
massie blue staining); running the same sample stored at 4 C
after 3 months does reveal a ladder of breakdown products
(data not shown). Although we had initially expected to have
grown crystals of the N-terminal residues 18–230 of PhtA
from S. pneumoniae, we have instead crystallised a fragment
of this construct, which contains a single histidine triad re-
peat region. The ﬁnal model containing three individual his-
tidine triad repeats of approximately 54 residues 3 zinc ions
and 192 water molecules was reﬁned against all of the data
(72.55–1.2 A˚) to give a ﬁnal R factor of 11.2% and Rfree of
13.5% (Fig. 1).4. Crystal structure of PhtA-166–220
The molecular model ﬁtted well into the electron density
(Fig. 2A and B) and was built from Gln-166 to Gly-220 for
chain A, Gln-166 to Gly-220 for chain B and Gly-167 to
Gly-220 for chain C. The overall structure of PhtA histidine
triad repeat 2 (PhtA-166–220) is shown in Fig. 3. It is a single
domain molecule of approximately 54 amino acids with an
overall topology that consists of a single beta-sheet composed
of 3 anti-parallel strands connected by short loops, with a large
loop connecting the single alpha helix to the beta-sheet. The
secondary structure elements are as follows: b1 residues 181–184; b2 residues 188–193; b3 residues 196–201 and a1 residues
207–220.
In an initial eﬀort to gain clues about the possible biological
function of SP1175 (PhtA 166–220), its structure was com-
pared to the proteins of a known spatial structures in the Pro-
tein Data Bank (PDB) [33] using DALI [34]. The search was
performed against the PDB database in December 2004. This
process was attempted using the monomer, the dimer and
the full content of the asymmetric unit (a trimer) as the search
models. Searches using the monomer resulted in several com-
parable structures, showing the same overall fold were present
in the PDB, however none of which share the zinc binding site.
The zinc ion is chelated (bound) by NE1 of His-194, NE2 of
His-197, NE2 of His-199 and OD2 of Asp-173 at distances of
2.02, 2.03, 2.03 and 1.97 A˚. The zinc coordinating atoms form
a distorted tetrahedral coordination sphere for the zinc ion.
The three histidine residues form the base of the triangle,
with the zinc ion sitting slightly above the plane of these
residues, the apex of the triangle is formed by the side chain
of Asp-173. The distances between the side chain atoms and
the zinc ion are shorter than expected, typical distances of pro-
tein to zinc ions are 2.2 A˚ between zinc and histidine and 2.1 A˚
for zinc and aspartic acid residues.
On viewing the three individual histidine triad proteins in the
asymmetric unit we have chains A, B and C; the interaction be-
tween chain A and B is weak involving only 10% of the total
surface area (402 A˚2) whilst the interaction of chains A and
C involve a surface area that is almost double, 18.5% of the to-
tal surface area is involved in the interaction forming a tight
interface. This dimerisation causes the beta sheet to be doubled
in length from 3 anti-parallel strands to 6 anti-parallel strands.
The third molecule in the asymmetric unit has its dimer part-
ner in the adjacent asymmetric unit (Fig. 4).5. Molecular modelling of the 4 remaining histidine triad repeats
Using the crystal structure, we have constructed models of
the remaining 4 histidine triad repeat regions from PhtA
(Fig. 5). Whilst the presence of the HxxHxH motif is obvious
for all 5 repeats, modelling has revealed that only 3 of the 5
repeats would be able to bind zinc in the same manner.
Repeats 2, 3 and 4 show the zinc ion is held in place in a
tetrahedral coordination, by three histidines from the above
motif, and an oxygen from the side chain of Aspartic acid
173. In histidine triad repeat 1, this aspartic acid residue has
been replaced by an arginine residue, whilst in histidine triad
repeat 5 the aspartic acid has been replaced with a valine
residue. Attempts to model neighbouring residues to better
coordinate the zinc have failed. It is possible that a complete
structural rearrangement occurs in this region and that the
tetrahedral geometry is maintained by a solvent molecule or
the side chain atoms from a residue not located adjacent to
the histidine triad repeat site.6. Proteins identiﬁed by DALI
Using theweb-based serverFASTAlignment andSearchTool
(http://biowulf.bu.edu/FAST) it was possible to overlay (based
on secondary structure elements) the structures which appear
to have a similar fold as they were retrieved after a DALI search
Fig. 1. Sequence alignment of the 4 Pht proteins from Streptococcus pneumoniae. Identical residues are in white on a red background.
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ties between the PhtA fragment and structures 1AZP (DNA
binding protein); 1TUX (neutrophil activating protein) and3IL8 (interleukin 8) can be seen in Fig. 6A, B and C using only
a C-alpha trace. Although the overall fold of these 4 protein
structures is remarkably similar, the level of identity at the se-
Fig. 2. (A) The experimental electron map after SHARP/SOLOMON. (B) The same area after model building with ARP/wARP.
Fig. 3. Stereo view of the asymmetric unit containing three copes of PhtA-166–220. Zinc ions are shown in grey. Chain A in Gold, chain B in Green
and chain C in Blue. Residues involved in co-ordination of the zinc ion are shown as ball and stick.
Fig. 4. Stereo view of the zinc binding site of PhtA-166–220. The residues involved in co-ordination of the zinc ion are shown as ball and stick.
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166–220 and each of the three proteins were undertaken (data
not shown)which revealed a higher level of sequence identity be-
tween PhtA-166–220 and 1TUX and 3IL8, whilst there was vir-
tually no identity between PhtA-166–220 and 1AZP, despite
having the best ﬁt structurally.The folds of 1AZP and PhtA-166–220 are very similar with
and average rmsd of 3.21 A˚ for 51 C-Alpha atoms. The loop
containing the histidine repeat in PhtA is elongated in 1AZP,
1AZP does not contain the residues to enable zinc binding.
The residues of 1AZP involved in DNA binding are not
conserved in PhtA-166–220. For both 1TUX and 3IL8, the
Fig. 5. Homology models of the 5 histidine triad domains found in PhtA. Only the 2nd (crystal structure), 3rd and 4th repeats contain the correct
amino acids to bind a zinc ion. In the ﬁrst repeat the aspartic acid is replaced with an arginine, whilst in the 5th repeat the aspartic acid is replaced
with a valine.
Fig. 6. Stereo views of PhtA-166–220 (purple) and structural homologues. (A) DNA binding protein 1AZP (yellow), (B) neutrophil activating
protein 1TUX (light green) and (C) interleukin 8 3IL8 (green). Whilst 1AZP has the best ﬁt, it has the lowest sequence identity (D).
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respectively. Attempts were also made to overlay the structures
of other zinc binding proteins belonging to the carbonic anhy-
drase family (1CAM and 1CSS). This was attempted using both
secondary structure elements and residues involved in zinc
binding, neither of these resulted in satisfactory overlays.7. Conclusion
Although on collecting data and solving the structure, we ex-
pected to see a single polypeptide of 212 amino acids we have
instead solved the crystal structure of a novel zinc binding do-
main (a degraded version of the N-terminal of PhtA which
contains residues 166–220). These residues represent a novel
manner for the sequestration of zinc ions contained within a
single histidine triad repeat motif (HxxHxH). This motif must
be incredibly stable as it has not been digested/degraded along
with the rest of the protein. The residues 166–220 contain the
ﬁnal histidine triad motif (of the three present in the original
construct). Protein functional analysis suggested that in situa-
tions where the bacteria face a zinc-restricted environment, the
expression of the Pht proteins would be induced and result in
Streptococcus adhesion and invasion [31]. Searches using a sin-
gle histidine triad repeat, the dimer of the histidine triad re-
peat and the total content of the asymmetric unit have been
used as search models gave a number of solutions in DALI
[34] in which the overall fold (3 strands and an alpha helix)
is preserved.
Although the structure of PhtA-166–220 shows an overall
fold similarity to DNA binding proteins, interleukin-8 and
neutrophil-activating proteins, further experimental work is
necessary to show if PhtA (PhtA-166–220) has any similar
activity or not.
A BLAST search of the Swiss-Prot protein database using
residues 166–220 revealed the only similarities to be proteins
of Streptococcus origin. The ﬁnding that this sequence is not
found within any other organism is not surprising as a search
using the complete sequence only produces hits with Pht pro-
teins from other streptococci.References
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